Publications by category
Books
Hartley S (eds)(2018).
Science and the Politics of Openness Here be Monsters.Abstract:
Science and the Politics of Openness Here be Monsters
Abstract.
Brunk CG, Hartley S (eds)(2012).
Designer Animals Mapping the Issues in Animal Biotechnology., University of Toronto Press.
Abstract:
Designer Animals Mapping the Issues in Animal Biotechnology
Abstract.
Journal articles
Hartley S, McLeod C, Clifford M, Jewitt S, Ray C (2019). A retrospective analysis of responsible innovation for low-technology innovation in the Global South.
Journal of Responsible Innovation,
6(2), 143-162.
Abstract:
A retrospective analysis of responsible innovation for low-technology innovation in the Global South
© 2019, © 2019 the Author(s). Published by Informa UK Limited, trading as Taylor. &. Francis Group. The role of low-technology innovation in addressing global challenges is undervalued. Responsible innovation (RI) has the potential to direct low-technology innovation toward global challenges in the Global South, yet this possibility remains largely unexplored. Through a retrospective analysis, this article explores how researchers grapple with dimensions of an RI framework in a research project and highlights key areas for researchers to consider when involved with low-technology innovation in a development context. The analysis demonstrates that RI can structure discussion and create space for anticipation, reflection and engagement with stakeholders. However, even when researchers are committed to the idea of RI, it is difficult to enact in practice. Although RI places significant emphasis on inclusive and meaningful engagement as imagined by co-development and inclusive models of innovation, the deficit model of public engagement presents a formidable barrier. Surprisingly, low-technology innovators are likely to face the same struggles as high technology innovators with regards to engagement that allows end-users to shape the technology which may ultimately benefit them.
Abstract.
Full text.
DOI.
Thizy D, Emerson C, Gibbs J, Hartley S, Kapiriri L, Lavery J, Lunshof J, Ramsey J, Shapiro J, Singh J, et al (2019). Guidance on stakeholder engagement practices to inform the development of area-wide vector control methods.
PLoS Neglected Tropical Diseases Full text.
DOI.
Rosemann A, Balen A, Nerlich B, Hauskeller C, Sleeboom‐Faulkner M, Hartley S, Zhang X, Lee N (2019). Heritable Genome Editing in a Global Context: National and International Policy Challenges.
Hastings Center Report,
49(3) Full text.
DOI.
Hartley S, Thizy D, Ledingham K, Coulibaly M, Diabaté A, Dicko D, Diop S, Kayondo J, Namukwaya A, Nourou B, et al (2019). Knowledge engagement in gene drive research for malaria control.
PLoS Neglected Tropical Diseases Full text.
DOI.
De Graeff N, Jongsma KR, Johnston J, Hartley S, Bredenoord AL (2019). The ethics of genome editing in non-human animals: a systematic review of reasons reported in the academic literature.
Philosophical Transactions of the Royal Society B: Biological Sciences,
374(1772).
Abstract:
The ethics of genome editing in non-human animals: a systematic review of reasons reported in the academic literature
© 2019 the Author(s) Published by the Royal Society. All rights reserved. In recent years, new genome editing technologies have emerged that can edit the genome of non-human animals with progressively increasing efficiency. Despite ongoing academic debate about the ethical implications of these technologies, no comprehensive overview of this debate exists. To address this gap in the literature, we conducted a systematic review of the reasons reported in the academic literature for and against the development and use of genome editing technologies in animals. Most included articles were written by academics from the biomedical or animal sciences. The reported reasons related to seven themes: human health, efficiency, risks and uncertainty, animal welfare, animal dignity, environmental considerations and public acceptability. Our findings illuminate several key considerations about the academic debate, including a low disciplinary diversity in the contributing academics, a scarcity of systematic comparisons of potential consequences of using these technologies, an underrepresentation of animal interests, and a disjunction between the public and academic debate on this topic. As such, this article can be considered a call for a broad range of academics to get increasingly involved in the discussion about genome editing, to incorporate animal interests and systematic comparisons, and to further discuss the aims and methods of public involvement. This article is part of a discussion meeting issue 'The ecology and evolution of prokaryotic CRISPR-Cas adaptive immune systems'.
Abstract.
Full text.
DOI.
Ribeiro B, Hartley S, Nerlich B, Jaspal R (2018). Media coverage of the Zika crisis in Brazil: the construction of a ‘war’ frame that masked social and gender inequalities.
Social Science & Medicine,
200, 137-144.
Full text.
DOI.
Pearce W, Hartley S, Helliwell R, O'Neill L (2018). Reply to Tagliabue.
EMBO reports,
19(4), e45954-e45954.
Full text.
DOI.
Wickson F, Preston C, Binimelis R, Herrero A, Hartley S, Wynberg R, Wynne B (2017). Addressing Socio-Economic and Ethical Considerations in Biotechnology Governance: the Potential of a New Politics of Care.
Food Ethics,
1(2), 193-199.
Full text.
DOI.
Hartley S, Pearce W, Taylor A (2017). Against the tide of depoliticisation: the politics of research governance.
Policy & Politics,
45(3), 361-377.
Full text.
DOI.
Hyde R, Hartley S, Millar K (2017). European novel foods policy at a critical juncture: Drawing lessons for future Novel Food Regulation through a retrospective examination of Regulation EC 258/97.
Food and Drug Law Journal,
72 (3), 472-505.
Full text.
McLeod C, Hartley S (2017). Responsibility and Laboratory Animal Research Governance.
Science, Technology, and Human Values Full text.
de Campos A, Hartley S, de Koning C, Lezaun J, Velho L (2017). Responsible innovation and political accountability: genetically modified mosquitoes in Brazil.
Journal of Responsible Innovation,
4 (1), 5-23.
Full text.
DOI.
Helliwell R, Hartley S, Pearce W, O'Neill L (2017). Why are NGOs sceptical of genome editing?.
EMBO reports,
18(12), 2090-2093.
Full text.
DOI.
Hartley S, Gillund F, van Hove L, Wickson F (2016). Essential Features of Responsible Governance of Agricultural Biotechnology.
PLOS Biology,
14(5), e1002453-e1002453.
Full text.
DOI.
Pearce W, Hartley S, Nerlich B (2016). Transparency: issues are not that simple.
Nature,
531(7592), 35-35.
Full text.
DOI.
Macnaghten P, Owen R, Stilgoe J, Wynne B, Azevedo A, Campo ALSD, Chilvers J, Dagnino R, Giulio GD, Frow E, et al (2015). Inovação responsável através de fronteiras: tensões, paradoxos e possibilidades.
Teoria e Pesquisa,
24(2), 18-24.
DOI.
Hartley S (2015). Policy masquerading as science: an examination of non-state actor involvement in European risk assessment policy for genetically modified animals.
Journal of European Public Policy,
23(2), 276-295.
Full text.
DOI.
Macnaghten PM, Owen RJ, Stilgoe J, Wynne B (2014). Responsible innovation across borders: tensions, paradoxes and possibilities.
Journal of Responsible Innovation,
1(2), 191-199.
DOI.
Hartley S, Millar KM (2014). The Challenges of Consulting the Public on Science Policy: Examining the Development of European Risk Assessment Policy for Genetically Modified Animals.
Review of Policy Research,
31(6), 481-502.
Full text.
DOI.
Hartley S, Scott DN (2006). Out-of-bounds? Resisting discursive limits in the debate over food biotechnology. Canadian Review of Social Policy
Hartley S, skogstad G (2005). Regulating genetically modified crops and foods in Canada and the United Kingdom: Democratizing risk regulation.
Canadian Public Administration/Administration publique du Canada,
48(3), 305-327.
DOI.
Chapters
Hartley S (2016). The treatment of social and ethical concerns in policy responses to agricultural biotechnology: an historical analysis. In (Ed) The intellectual property–regulatory complex: Overcoming barriers to innovation in agricultural genomics.
Brunk CG, Hartley S, Rodgers LC (2012). Focusing on the values in debates about animal biotechnology. In (Ed) Designer animals: Mapping the issues in animal biotechnology.
Brunk C, Hartley S (2012). Issues of governance in animal biotechnology. In (Ed) Designer animals: Mapping the issues in animal biotechnology.
Skogstad G, Hartley S (2007). Science and policy-making: the legitimation conundrum. In (Ed) Public science in liberal democracy: the challenge to science and democracy.
Publications by year
2019
Hartley S, McLeod C, Clifford M, Jewitt S, Ray C (2019). A retrospective analysis of responsible innovation for low-technology innovation in the Global South.
Journal of Responsible Innovation,
6(2), 143-162.
Abstract:
A retrospective analysis of responsible innovation for low-technology innovation in the Global South
© 2019, © 2019 the Author(s). Published by Informa UK Limited, trading as Taylor. &. Francis Group. The role of low-technology innovation in addressing global challenges is undervalued. Responsible innovation (RI) has the potential to direct low-technology innovation toward global challenges in the Global South, yet this possibility remains largely unexplored. Through a retrospective analysis, this article explores how researchers grapple with dimensions of an RI framework in a research project and highlights key areas for researchers to consider when involved with low-technology innovation in a development context. The analysis demonstrates that RI can structure discussion and create space for anticipation, reflection and engagement with stakeholders. However, even when researchers are committed to the idea of RI, it is difficult to enact in practice. Although RI places significant emphasis on inclusive and meaningful engagement as imagined by co-development and inclusive models of innovation, the deficit model of public engagement presents a formidable barrier. Surprisingly, low-technology innovators are likely to face the same struggles as high technology innovators with regards to engagement that allows end-users to shape the technology which may ultimately benefit them.
Abstract.
Full text.
DOI.
Thizy D, Emerson C, Gibbs J, Hartley S, Kapiriri L, Lavery J, Lunshof J, Ramsey J, Shapiro J, Singh J, et al (2019). Guidance on stakeholder engagement practices to inform the development of area-wide vector control methods.
PLoS Neglected Tropical Diseases Full text.
DOI.
Rosemann A, Balen A, Nerlich B, Hauskeller C, Sleeboom‐Faulkner M, Hartley S, Zhang X, Lee N (2019). Heritable Genome Editing in a Global Context: National and International Policy Challenges.
Hastings Center Report,
49(3) Full text.
DOI.
Hartley S, Thizy D, Ledingham K, Coulibaly M, Diabaté A, Dicko D, Diop S, Kayondo J, Namukwaya A, Nourou B, et al (2019). Knowledge engagement in gene drive research for malaria control.
PLoS Neglected Tropical Diseases Full text.
DOI.
De Graeff N, Jongsma KR, Johnston J, Hartley S, Bredenoord AL (2019). The ethics of genome editing in non-human animals: a systematic review of reasons reported in the academic literature.
Philosophical Transactions of the Royal Society B: Biological Sciences,
374(1772).
Abstract:
The ethics of genome editing in non-human animals: a systematic review of reasons reported in the academic literature
© 2019 the Author(s) Published by the Royal Society. All rights reserved. In recent years, new genome editing technologies have emerged that can edit the genome of non-human animals with progressively increasing efficiency. Despite ongoing academic debate about the ethical implications of these technologies, no comprehensive overview of this debate exists. To address this gap in the literature, we conducted a systematic review of the reasons reported in the academic literature for and against the development and use of genome editing technologies in animals. Most included articles were written by academics from the biomedical or animal sciences. The reported reasons related to seven themes: human health, efficiency, risks and uncertainty, animal welfare, animal dignity, environmental considerations and public acceptability. Our findings illuminate several key considerations about the academic debate, including a low disciplinary diversity in the contributing academics, a scarcity of systematic comparisons of potential consequences of using these technologies, an underrepresentation of animal interests, and a disjunction between the public and academic debate on this topic. As such, this article can be considered a call for a broad range of academics to get increasingly involved in the discussion about genome editing, to incorporate animal interests and systematic comparisons, and to further discuss the aims and methods of public involvement. This article is part of a discussion meeting issue 'The ecology and evolution of prokaryotic CRISPR-Cas adaptive immune systems'.
Abstract.
Full text.
DOI.
2018
Ribeiro B, Hartley S, Nerlich B, Jaspal R (2018). Media coverage of the Zika crisis in Brazil: the construction of a ‘war’ frame that masked social and gender inequalities.
Social Science & Medicine,
200, 137-144.
Full text.
DOI.
Pearce W, Hartley S, Helliwell R, O'Neill L (2018). Reply to Tagliabue.
EMBO reports,
19(4), e45954-e45954.
Full text.
DOI.
Hartley S (eds)(2018).
Science and the Politics of Openness Here be Monsters.Abstract:
Science and the Politics of Openness Here be Monsters
Abstract.
2017
Wickson F, Preston C, Binimelis R, Herrero A, Hartley S, Wynberg R, Wynne B (2017). Addressing Socio-Economic and Ethical Considerations in Biotechnology Governance: the Potential of a New Politics of Care.
Food Ethics,
1(2), 193-199.
Full text.
DOI.
Hartley S, Pearce W, Taylor A (2017). Against the tide of depoliticisation: the politics of research governance.
Policy & Politics,
45(3), 361-377.
Full text.
DOI.
Hyde R, Hartley S, Millar K (2017). European novel foods policy at a critical juncture: Drawing lessons for future Novel Food Regulation through a retrospective examination of Regulation EC 258/97.
Food and Drug Law Journal,
72 (3), 472-505.
Full text.
McLeod C, Hartley S (2017). Responsibility and Laboratory Animal Research Governance.
Science, Technology, and Human Values Full text.
de Campos A, Hartley S, de Koning C, Lezaun J, Velho L (2017). Responsible innovation and political accountability: genetically modified mosquitoes in Brazil.
Journal of Responsible Innovation,
4 (1), 5-23.
Full text.
DOI.
Helliwell R, Hartley S, Pearce W, O'Neill L (2017). Why are NGOs sceptical of genome editing?.
EMBO reports,
18(12), 2090-2093.
Full text.
DOI.
2016
Hartley S, Gillund F, van Hove L, Wickson F (2016). Essential Features of Responsible Governance of Agricultural Biotechnology.
PLOS Biology,
14(5), e1002453-e1002453.
Full text.
DOI.
Hartley S (2016). The treatment of social and ethical concerns in policy responses to agricultural biotechnology: an historical analysis. In (Ed) The intellectual property–regulatory complex: Overcoming barriers to innovation in agricultural genomics.
Pearce W, Hartley S, Nerlich B (2016). Transparency: issues are not that simple.
Nature,
531(7592), 35-35.
Full text.
DOI.
2015
Macnaghten P, Owen R, Stilgoe J, Wynne B, Azevedo A, Campo ALSD, Chilvers J, Dagnino R, Giulio GD, Frow E, et al (2015). Inovação responsável através de fronteiras: tensões, paradoxos e possibilidades.
Teoria e Pesquisa,
24(2), 18-24.
DOI.
Hartley S (2015). Policy masquerading as science: an examination of non-state actor involvement in European risk assessment policy for genetically modified animals.
Journal of European Public Policy,
23(2), 276-295.
Full text.
DOI.
2014
Macnaghten PM, Owen RJ, Stilgoe J, Wynne B (2014). Responsible innovation across borders: tensions, paradoxes and possibilities.
Journal of Responsible Innovation,
1(2), 191-199.
DOI.
Hartley S, Millar KM (2014). The Challenges of Consulting the Public on Science Policy: Examining the Development of European Risk Assessment Policy for Genetically Modified Animals.
Review of Policy Research,
31(6), 481-502.
Full text.
DOI.
2012
Brunk CG, Hartley S (eds)(2012).
Designer Animals Mapping the Issues in Animal Biotechnology., University of Toronto Press.
Abstract:
Designer Animals Mapping the Issues in Animal Biotechnology
Abstract.
Brunk CG, Hartley S, Rodgers LC (2012). Focusing on the values in debates about animal biotechnology. In (Ed) Designer animals: Mapping the issues in animal biotechnology.
Brunk C, Hartley S (2012). Issues of governance in animal biotechnology. In (Ed) Designer animals: Mapping the issues in animal biotechnology.
2007
Skogstad G, Hartley S (2007). Science and policy-making: the legitimation conundrum. In (Ed) Public science in liberal democracy: the challenge to science and democracy.
2006
Hartley S, Scott DN (2006). Out-of-bounds? Resisting discursive limits in the debate over food biotechnology. Canadian Review of Social Policy
2005
Hartley S, skogstad G (2005). Regulating genetically modified crops and foods in Canada and the United Kingdom: Democratizing risk regulation.
Canadian Public Administration/Administration publique du Canada,
48(3), 305-327.
DOI.
